Background Sham-controlled trials demonstrated safety and efficacy of renal denervation
(RDN) to lower blood pressure (BP). Association of baseline heart rate with BP reduction …

Aims The randomized sham-controlled SPYRAL HTN-OFF MED trial demonstrated that
renal denervation (RDN) using a multi-electrode catheter lowers ambulatory blood pressure …

Background Renal denervation (RDN) reduces blood pressure (BP) in patients with
uncontrolled hypertension in the absence of antihypertensive medications. Objectives This …

BACKGROUND: The SPYRAL HTN-ON MED (Global Clinical Study of Renal Denervation
With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With …

Background: Prior studies of catheter-based renal artery denervation have not systematically
performed ambulatory blood pressure monitoring (ABPM) to assess the efficacy of the …

Background It is unclear whether renal denervation (RDN) can safely result in blood
pressure (BP) reductions in Asian hypertensive patients and whether such reductions would …

Introduction Studies on the blood pressure lowering effect of renal denervation (RDN) in
resistant hypertensive patients have produced conflicting results. Change in medication …

Objectives The aim of this study was to investigate bipolar radiofrequency renal denervation
in patients with hypertension not receiving medications at baseline. Background A blood …

Renal denervation (RD) has been investigated as a novel blood pressure (BP) lowering
treatment for hypertension. The primary objective of this meta-analysis was to assess the …

Objectives: Renal denervation (RDN) can reduce sympathetic activity and blood pressure
(BP) in patients with hypertension. The effects on resting and ambulatory heart rate (HR) …